Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Brachytherapy after coronary interventions: current state and future perspectives].

C K Naber1, C A Kaiser, W Sauerwein

  • 1Abteilung für Kardiologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122 Essen, Germany. christoph-naber@uni-essen.de

Zeitschrift Fur Kardiologie
|January 25, 2003
PubMed
Summary

Intracoronary brachytherapy effectively reduces restenosis after coronary interventions, especially for in-stent restenosis. This established therapy is safe and effective for up to five years, offering a treatment option for high-risk patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mechanical circulatory support systems : When and how much protection does a PCI need?]

Herz·2022
Same author

Intra-pericardial thrombin injection as bailout strategy in iatrogenic pericardial tamponade.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022
Same author

Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments.

Clinical research in cardiology : official journal of the German Cardiac Society·2019
Same author

[Acute coronary syndrome with ST-elevation].

Herz·2019
Same author

The German CPU registry: Comparison of smokers and nonsmokers.

Herz·2018
Same author

[Management of valvular heart disease : ESC/EACTS guidelines 2017].

Herz·2017

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Radiation Oncology

Context:

  • Intracoronary brachytherapy is an established interventional procedure for managing coronary artery disease.
  • Restenosis remains a significant challenge after percutaneous coronary interventions, particularly in complex lesions.

Purpose:

  • To evaluate the efficacy and safety of intracoronary brachytherapy in reducing restenosis rates after coronary interventions.
  • To assess the long-term outcomes of intracoronary brachytherapy for various patient subgroups and lesion types.

Summary:

  • Intracoronary brachytherapy is the only interventional procedure proven to reduce restenosis in long and diffuse in-stent restenosis, making it the treatment of choice.
  • Randomized studies show promising results for bypass interventions, small vessels, and diabetic patients, supporting its use in high-risk individuals.

Related Experiment Videos

  • While effective for de novo lesions in studies, it's not routine; careful patient selection and sufficient radiation source length are crucial to prevent edge restenosis and minimize late stent thrombosis risk with adequate antiplatelet therapy.

    • Impact:

    • Intracoronary brachytherapy offers a safe and effective mid-term solution for reducing restenosis after coronary interventions, with up to 5-year follow-up data supporting its efficacy.
    • Findings may encourage percutaneous transluminal interventions in high-risk patients, improving clinical decision-making.
    • Minimizing late stent thrombosis through adequate antiplatelet therapy is essential for optimal outcomes.